Cuba launches clinic for chikungunya aftereffects

The Institute of Neurology and Neurosurgery in Cuba has begun a specialized clinic to care for patients with post-chikungunya ailments, particularly those linked to neuropathic pain, joint pain, and paresthesia. This step provides focused treatment for individuals impacted by the mosquito-borne virus.

In Havana on December 23, the Institute of Neurology and Neurosurgery in Cuba has launched a specialized clinic dedicated to treating patients with post-chikungunya ailments. The facility focuses on conditions such as neuropathic pain, joint pain, and paresthesia, which are common lingering effects of the mosquito-borne chikungunya virus that causes fever and severe aches.

Chikungunya can lead to long-term complications that impair daily life for those infected. The new clinic aims to address these persistent issues through comprehensive care. As reported by Prensa Latina, this opening meets the demand for specialized health services in Cuba.

While specific patient numbers are not yet available, the clinic is part of Cuba's public health efforts to manage infectious diseases and their neurological aftermaths. This initiative highlights Cuba's dedication to accessible medical treatment for virus-related conditions.

Verwandte Artikel

Comparative illustration of long COVID patients: US woman with severe brain fog and anxiety versus milder symptoms in India, Nigeria, and Colombia, per international study.
Bild generiert von KI

International study finds U.S. long COVID patients report more brain fog and psychological symptoms than peers in India and Nigeria

Von KI berichtet Bild generiert von KI Fakten geprüft

A Northwestern Medicine-led study of more than 3,100 adults with long COVID found that non-hospitalized participants in the United States reported substantially higher rates of brain fog, depression/anxiety and insomnia than participants in Colombia, Nigeria and India—differences the researchers say likely reflect cultural factors and access to care as much as biology.

Der kubanische Präsident Miguel Díaz-Canel legte vorläufige positive Ergebnisse aus klinischen Studien des Biotechnologiemedikaments Jusvinza bei Patienten mit chronischer post-Chikungunya-Arthritis vor. Die im Dezember 2025 gestarteten Studien zeigen deutliche Verbesserungen in Provinzen wie Havanna und Matanzas. Experten heben das Sicherheitsprofil des Medikaments und sein Potenzial zur Verlangsamung der Entzündung hervor.

Von KI berichtet

Kuba weist eine günstige epidemiologische Situation in der Bekämpfung von Arboviren auf, nach einem Rückgang der gemeldeten Fieberfälle um 21 Prozent in der vergangenen Woche. Diese Verbesserung unterstreicht die effektiven Bemühungen zur Kontrolle von Vektorkrankheiten wie Dengue und Zika. Gesundheitsbehörden betonen die Notwendigkeit anhaltender Wachsamkeit.

New research challenges long-standing concerns about the antiviral drug oseltamivir, known as Tamiflu, and its potential link to serious neuropsychiatric events in children. Instead, the study attributes such symptoms to the influenza virus itself and shows that Tamiflu treatment halves the risk of these complications. The findings, based on a large analysis of pediatric health records, aim to reassure families and doctors about the drug's safety.

Von KI berichtet

A genetic technology called a gene drive has shown promise in preventing malaria transmission by mosquitoes during lab tests in Tanzania. Researchers modified local mosquitoes to produce antimalarial proteins, demonstrating effective inhibition of parasites from infected children. The findings suggest the approach could work in the field if released.

Das Hatuey-Projekt, eine US-basierte Solidaritätsinitiative, hat Spenden von Materialien und Medikamenten für die Behandlung von Kinderkrebs an zwei kubanische Krankenhäuser geliefert. Dies ist das achte Mal, dass sie das Gesundheitssystem der Insel inmitten der US-Wirtschaftsblockade unterstützen. Die Projektkoordinatorin bekräftigte bei einer Veranstaltung in Havanna ein unerschütterliches Engagement für Kuba.

Von KI berichtet Fakten geprüft

Scientists at the University of Queensland have captured the first near‑atomic, high‑resolution 3D images of the yellow fever virus, detailing how the surface of the long‑used vaccine strain differs from virulent, disease‑causing strains. The work sheds light on how the virus is recognised by the immune system and could support improved vaccines for yellow fever and related mosquito‑borne diseases.

 

 

 

Diese Website verwendet Cookies

Wir verwenden Cookies für Analysen, um unsere Website zu verbessern. Lesen Sie unsere Datenschutzrichtlinie für weitere Informationen.
Ablehnen